CNTX

SEC source: 0001628280-26-045762 · wk-form4_1782504828.xml · derivative · entry 1

Kantoff Philip W. · CIK 0001866025 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2036-06-23

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001628280-26-045780 · wk-form4_1782505258.xml · derivative · entry 1

West Linda · CIK 0001805257 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2036-06-23

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001628280-26-045775 · wk-form4_1782505176.xml · derivative · entry 1

Walker Luke Nathaniel · CIK 0001701440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2036-06-23

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001628280-26-045784 · wk-form4_1782505299.xml · derivative · entry 1

Stacey Jennifer Evans · CIK 0001321326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2036-06-23

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001628280-26-045778 · wk-form4_1782505215.xml · derivative · entry 1

Smith Karen L. · CIK 0001639637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2036-06-23

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001628280-26-045789 · wk-form4_1782505405.xml · derivative · entry 1

Pasternak Andy · CIK 0001792746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2036-06-23

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 24, 2027 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2027 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001628280-26-010642 · wk-form4_1771881698.xml · derivative · entry 1

Minai-Azary Jennifer Lynn · CIK 0001844398 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 275,000

Underlying: Common Stock · 275,000 shares

Expires 2036-02-18

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001628280-26-010660 · wk-form4_1771881890.xml · derivative · entry 1

Levit Alex C. · CIK 0001862840 · Chief Legal Officer, Corp. Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Stock · 270,000 shares

Expires 2036-02-18

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001628280-26-010616 · wk-form4_1771881235.xml · derivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 815,000

Underlying: Common Stock · 815,000 shares

Expires 2036-02-18

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001628280-26-010637 · wk-form4_1771881526.xml · derivative · entry 1

Chagin Karen Deborah · CIK 0002070710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 290,000

Underlying: Common Stock · 290,000 shares

Expires 2036-02-18

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 19, 2027, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-25-000077 · wk-form4_1749763711.xml · derivative · entry 1

Kantoff Philip W. · CIK 0001866025 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,500

Underlying: Common Stock · 123,500 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-25-000073 · wk-form4_1749763407.xml · derivative · entry 1

West Linda · CIK 0001805257 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,500

Underlying: Common Stock · 123,500 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-25-000074 · wk-form4_1749763486.xml · derivative · entry 1

Walker Luke Nathaniel · CIK 0001701440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,500

Underlying: Common Stock · 123,500 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-25-000075 · wk-form4_1749763548.xml · derivative · entry 1

Stacey Jennifer Evans · CIK 0001321326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,500

Underlying: Common Stock · 123,500 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-25-000076 · wk-form4_1749763615.xml · derivative · entry 1

Smith Karen L. · CIK 0001639637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,500

Underlying: Common Stock · 123,500 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-25-000078 · wk-form4_1749763803.xml · derivative · entry 1

Pasternak Andy · CIK 0001792746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,900

Underlying: Common Stock · 138,900 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-25-000056 · wk-form4_1749504091.xml · derivative · entry 1

Chagin Karen Deborah · CIK 0002070710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,000

Underlying: Common Stock · 153,000 shares

Expires 2035-06-08

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on June 9, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-25-000064 · wk-form4_1749590774.xml · nonDerivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · Martin Lehr 2000 Trust

Disclosed balance after: 920,190

F1 · price: The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.6682 - $0.75. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001842952-25-000060 · wk-form4_1749590535.xml · nonDerivative · entry 1

Minai-Azary Jennifer Lynn · CIK 0001844398 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,010

F1 · price: The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.57 - $0.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001842952-25-000062 · wk-form4_1749590621.xml · nonDerivative · entry 1

Levit Alex C. · CIK 0001862840 · Chief Legal Officer, Corp. Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,000

F1 · price: The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.56 - $0.58. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001842952-25-000022 · wk-form4_1739567592.xml · derivative · entry 1

Minai-Azary Jennifer Lynn · CIK 0001844398 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 371,800

Underlying: Common Stock · 371,800 shares

Expires 2035-02-12

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-25-000020 · wk-form4_1739567246.xml · derivative · entry 1

Dansky Ullmann Claudio · CIK 0002030789 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,960

Underlying: Common Stock · 174,960 shares

Expires 2035-02-12

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-25-000021 · wk-form4_1739567504.xml · derivative · entry 1

Levit Alex C. · CIK 0001862840 · Chief Legal Officer, Corp. Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,900

Underlying: Common Stock · 349,900 shares

Expires 2035-02-12

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-25-000019 · wk-form4_1739567178.xml · derivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 802,700

Underlying: Common Stock · 802,700 shares

Expires 2035-02-12

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2026, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-25-000010 · wk-form4_1736905424.xml · derivative · entry 1

Pasternak Andy · CIK 0001792746 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,685

Underlying: Common Stock · 20,685 shares

Expires 2035-01-12

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-24-000077 · wk-form4_1725537887.xml · derivative · entry 1

Walker Luke Nathaniel · CIK 0001701440 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,315

Underlying: Common Stock · 19,315 shares

Expires 2034-09-03

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-24-000079 · wk-form4_1725538497.xml · derivative · entry 1

Smith Karen L. · CIK 0001639637 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,315

Underlying: Common Stock · 19,315 shares

Expires 2034-09-03

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 13, 2025 or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-24-000062 · wk-form4_1722547103.xml · derivative · entry 1

Dansky Ullmann Claudio · CIK 0002030789 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,170

Underlying: Common Stock · 202,170 shares

Expires 2034-07-31

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on August 1, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-24-000042 · wk-form4_1718365295.xml · derivative · entry 1

BERMAN RICHARD J · CIK 0001111620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-24-000046 · wk-form4_1718365807.xml · derivative · entry 1

Kantoff Philip W. · CIK 0001866025 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-24-000044 · wk-form4_1718365616.xml · derivative · entry 1

West Linda · CIK 0001805257 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-24-000048 · wk-form4_1718365971.xml · derivative · entry 1

Stacey Jennifer Evans · CIK 0001321326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-06-12

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) June 13, 2025 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2025 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-24-000019 · wk-form4_1711109066.xml · derivative · entry 1

Minai-Azary Jennifer Lynn · CIK 0001844398 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,115

Underlying: Common Stock · 160,115 shares

Expires 2034-03-20

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-24-000018 · wk-form4_1711108898.xml · derivative · entry 1

Levit Alex C. · CIK 0001862840 · Chief Legal Officer, Corp. Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,515

Underlying: Common Stock · 153,515 shares

Expires 2034-03-20

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-24-000017 · wk-form4_1711108859.xml · derivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 291,402

Underlying: Common Stock · 291,402 shares

Expires 2034-03-20

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on March 21, 2025, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-23-000059 · wf-form4_168556636136177.xml · derivative · entry 1

BERMAN RICHARD J · CIK 0001111620 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-23-000062 · wf-form4_168556641370866.xml · derivative · entry 1

Kantoff Philip W. · CIK 0001866025 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-23-000061 · wf-form4_168556639644192.xml · derivative · entry 1

West Linda · CIK 0001805257 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-23-000060 · wf-form4_168556637918497.xml · derivative · entry 1

Stacey Jennifer Evans · CIK 0001321326 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2033-05-30

F1 · derivative.exercise_date: The option vests and becomes exercisable on the earlier of (i) May 31, 2024 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2024 annual meeting of stockholders, subject to continued service with the Issuer.

SEC source: 0001842952-23-000030 · wf-form4_167702790361209.xml · nonDerivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,701

F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.

F2 · price: The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.8154 - $0.8470. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001842952-23-000020 · wf-form4_167632218722654.xml · nonDerivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,878

F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.

F2 · price: The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.8563 - $0.8938. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001842952-23-000026 · wf-form4_167641222454214.xml · derivative · entry 1

Minai-Azary Jennifer Lynn · CIK 0001844398 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 158,001

Underlying: Common Stock · 158,001 shares

Expires 2033-02-12

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-23-000028 · wf-form4_167641226007313.xml · derivative · entry 1

Levit Alex C. · CIK 0001862840 · Chief Legal Officer, Corp. Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 151,505

Underlying: Common Stock · 151,505 shares

Expires 2033-02-12

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-23-000027 · wf-form4_167641224437732.xml · derivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 287,544

Underlying: Common Stock · 287,544 shares

Expires 2033-02-12

F1 · derivative.exercise_date: The option vests and becomes exercisable over a four-year period. Twenty-five percent (25%) of the option vests and becomes exercisable on February 13, 2024, and the balance vests in equal monthly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.

SEC source: 0001842952-23-000017 · wf-form4_167571737374433.xml · nonDerivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,272

F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.

F2 · price: The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.9449 - $1.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001842952-23-000012 · wf-form4_167511259579472.xml · nonDerivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,232

F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.

F2 · price: The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.682 - $0.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001842952-23-000008 · wf-form4_167451138827052.xml · nonDerivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,205

F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.

F2 · price: The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.7052 - $0.7251. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001842952-23-000006 · wf-form4_167407584583579.xml · nonDerivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 129,366

F1 · kind: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.

F2 · price: The price reported above is a weighted average purchase price. These shares were acquired in several transactions at prices ranging from $0.7298 - $0.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001842952-22-000114 · wf-form4_167148450192465.xml · nonDerivative · entry 1

Minai-Azary Jennifer Lynn · CIK 0001844398 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

SEC source: 0001842952-22-000112 · wf-form4_167148401293928.xml · nonDerivative · entry 1

Lehr Martin A. · CIK 0001861989 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,583